Physicochemical Evaluation of Lyophilized Formulation of p-SCN-Bn-DOTA- and p-SCN-Bn-DTPA-rituximab for NHL Radio Immunotherapy

Radioimmunotherapy (RIT) of Non-Hodgkin’s lymphoma (NHL) is said to be more advantageous compared to unlabelled therapeutic antibodies. To this date, radiolabelled murine anti-CD20 mAbs, Zevalin(®) and Bexxar(®) have been approved for imaging and therapy. A preparation containing rituximab, chimeric...

Descripción completa

Detalles Bibliográficos
Autores principales: Ackova, Darinka Gjorgieva, Smilkov, Katarina, Janevik-Ivanovska, Emilija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149015/
https://www.ncbi.nlm.nih.gov/pubmed/27980563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149015/
https://www.ncbi.nlm.nih.gov/pubmed/27980563

Ejemplares similares